SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-21-000041
Filing Date
2021-12-13
Accepted
2021-12-13 16:32:03
Documents
12
Period of Report
2021-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20211207.htm   iXBRL 8-K 35339
  Complete submission text file 0001587221-21-000041.txt   171020

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20211207.xsd EX-101.SCH 1939
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20211207_lab.xml EX-101.LAB 23970
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20211207_pre.xml EX-101.PRE 12666
5 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20211207_htm.xml XML 10823
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 211488460
SIC: 2834 Pharmaceutical Preparations